Concert Pharmaceuticals, Inc.
PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS

Abstract:

Improved processes and intermediates for preparing ruxolitinib and deuterated analogs of ruxolitinib are disclosed.